Seeyond trimmed its position in Centene Corp (NYSE:CNC) by 23.9% in the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 24,343 shares of the company’s stock after selling 7,652 shares during the period. Seeyond’s holdings in Centene were worth $1,277,000 at the end of the most recent reporting period.
A number of other large investors have also recently bought and sold shares of CNC. Zions Bancorporation N.A. grew its stake in Centene by 131.5% in the first quarter. Zions Bancorporation N.A. now owns 602 shares of the company’s stock worth $32,000 after purchasing an additional 342 shares in the last quarter. Global Retirement Partners LLC lifted its holdings in Centene by 568.0% in the first quarter. Global Retirement Partners LLC now owns 648 shares of the company’s stock worth $34,000 after acquiring an additional 551 shares during the last quarter. Reilly Financial Advisors LLC lifted its holdings in Centene by 133.3% in the second quarter. Reilly Financial Advisors LLC now owns 700 shares of the company’s stock worth $37,000 after acquiring an additional 400 shares during the last quarter. Berman Capital Advisors LLC lifted its holdings in Centene by 369.3% in the first quarter. Berman Capital Advisors LLC now owns 826 shares of the company’s stock worth $43,000 after acquiring an additional 650 shares during the last quarter. Finally, Cullen Frost Bankers Inc. lifted its holdings in Centene by 1,566.7% in the second quarter. Cullen Frost Bankers Inc. now owns 900 shares of the company’s stock worth $47,000 after acquiring an additional 846 shares during the last quarter. Institutional investors and hedge funds own 97.76% of the company’s stock.
A number of equities analysts have issued reports on CNC shares. Deutsche Bank started coverage on shares of Centene in a report on Thursday. They issued a “buy” rating and a $62.00 target price on the stock. Zacks Investment Research cut shares of Centene from a “buy” rating to a “hold” rating and set a $49.00 target price on the stock. in a report on Monday, September 2nd. ValuEngine cut shares of Centene from a “sell” rating to a “strong sell” rating in a report on Tuesday, July 2nd. Finally, Morgan Stanley cut their target price on shares of Centene from $71.00 to $64.00 and set an “overweight” rating on the stock in a report on Friday, August 23rd. One investment analyst has rated the stock with a sell rating, three have given a hold rating and thirteen have given a buy rating to the company. The company presently has an average rating of “Buy” and a consensus target price of $73.10.
Centene (NYSE:CNC) last released its quarterly earnings results on Tuesday, July 23rd. The company reported $1.34 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.24 by $0.10. The company had revenue of $18.36 billion for the quarter, compared to analysts’ expectations of $18.02 billion. Centene had a return on equity of 15.87% and a net margin of 1.84%. The business’s revenue for the quarter was up 29.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.90 earnings per share. Equities research analysts anticipate that Centene Corp will post 4.42 EPS for the current year.
In other Centene news, Director Jessica L. Blume purchased 2,850 shares of the business’s stock in a transaction dated Friday, July 26th. The shares were bought at an average price of $52.99 per share, with a total value of $151,021.50. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 2.50% of the company’s stock.
Centene Company Profile
Centene Corporation operates as a diversified and multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. The company's Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term services and support, foster care, and medicare-medicaid plans, which covers dually eligible individuals, as well as aged, blind, or disabled programs.
Featured Story: Limitations to arbitrage trading
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.